Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Heatmap
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
AGEN
#3720
Agenus Inc.
4.7
2
USD
+13.73%
Secteur:
Soins de Santé
Base:
USD
Devise de Profit:
USD
Range quotidien
Range Annuel
Changement quotidien
+13.73%
Changement Mensuel
+51.28%
Evolution sur 6 mois
+18.30%
Changement Annuel
+159.34%
Clôture Précédente
4.1
5
Open
4.7
2
Bid
Ask
Low
4.7
2
High
4.7
2
Volume
112
Marchés
Actions des Marchés US
Soins de Santé
AGEN
Open full chart
Financials
Overview
Relevé
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
10.23 M
12.86 M
16.63 M
20.95 M
25.31 M
38.4 M
—
Valuation ratios
Enterprise value
563.66 M
563.46 M
646.84 M
294.43 M
86.74 M
155.58 M
577.37 M
Price to earnings ratio
—
—
-3.08
-1.16
-0.26
—
—
Price to sales ratio
—
—
0.01
0
0.57
0.82
3.16
Price to cash flow ratio
—
—
-0
-0
-0.37
-1.21
-3.34
Price to book ratio
—
—
-0.01
-0
-0.18
-0.34
-0.53
Enterprise value to EBITDA ratio
22.38
2.74
-4.13
-2.24
-0.9
-2.82
—
Profitability ratios
Return on assets %
-0.85
-0.06
-0.56
-0.82
-1.03
-0.01
-0.07
Return on equity %
0.86
-0.6
4.2
1.73
0.76
0.01
-0.02
Return on invested capital %
-283.64
51.12
-271.58
-193.14
-146.85
-26.66
—
Gross margin %
97.34
98.83
89.22
98.01
99.53
99.11
396.36
Operating margin %
-132.96
8.71
-183.04
-102.07
-116.44
-17.66
-93.29
EBITDA margin %
30.31
75.07
-173.63
-99.85
-147.14
-37.93
—
Net margin %
-207.43
-9.72
-235.31
-164.69
-224.5
-2.7
-46.04
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
0.88
2.12
1.13
0.44
0.21
0.41
1.05
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.48
0.87
0.22
0.43
0.38
0.5
0.54
Solvency ratios
Debt to assets ratio
0.1
0.03
0.05
0.07
0.17
0.2
0.71
Debt to equity ratio
-0.1
0.4
-0.34
-0.15
-0.12
-0.17
-0.49
Long term debt to total assets ratio
0.09
0.03
0.03
0.04
0.13
0
0.39
Long term debt to total equity ratio
-0.09
0.37
-0.21
-0.08
-0.09
0
-0.25
Per share metrics
Operating cash flow per share
—
—
-12.45 K
-12.53 K
-7.37
-2.6
-2.77
EBIT per share
—
—
-12.57 K
-9 627.85
-7.89
-1.89
0.35
EBITDA per share
—
—
-12.08 K
-8 722.54
-7.09
-1.46
—
Total debt per share
—
—
1 498.6
1 306.05
1.76
1.51
5.23
Cash per share
—
—
13.73 K
4 252.72
1.88
0.1
1.3
Net current asset value per share
—
—
15.13 K
6 282.17
2.12
4.49
9.98
Tangible book value per share
—
—
-6 599.84
-10.59 K
-16.48
-10.03
-47.87
Working capital per share
—
—
1 715.75
-8 018.18
-8.19
-6.39
-26.49
Book value per share
—
—
-4 349.92
-8 959.82
-15.2
-9.12
-44.04
Nouvelles
ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study
Agenus (AGEN) is a Great Momentum Stock: Should You Buy?
Agenus lance un essai de phase 3 pour le cancer colorectal
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus annonce le rejet d’un recours collectif en valeurs mobilières
B.Riley réitère son objectif de 8$ pour Agenus sur fond de croissance
Agenus (AGEN) Q4 Earnings and Revenues Surpass Estimates
Agenus annonce 4,2 M$ de revenus d’accès précoce pour sa thérapie anticancéreuse
Agenus reports $4.2M in early access revenue for cancer therapy
CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates
IBD Stock Of The Day: Ligand Pharma, Biotech's Royalty Arm, Breaks Out
Agenus reçoit un paiement de 20 millions $ dans le cadre de sa collaboration avec Zydus